E-Submission Part Of FDA Reg Reform Plan; Alzheimer’s Data Standard About To Debut
Executive Summary
Standards for organizing clinical data from research in some major diseases are taking shape as FDA moves to clear a regulatory path that eventually could allow all submissions to be done electronically.
You may also be interested in...
Sponsors Might Share Research Committees As Pressure Mounts To Share Data
Novartis official says the firm is considering using the same committee as other sponsors to review requests from researchers for data access; stakeholders ask for seats at the table and data interoperability.
Chelsea Vows To Resolve Latest Regulatory Woes With Northera Quickly
Technical deficiencies foil the resubmission of Chelsea Therapeutics’ Northera. The company thinks it can resolve the problems quickly and some analysts expect a relatively short delay of one or two months to the user fee date.
Track-and-Trace Bill Clears House With New Electronic Labeling Language
Safeguarding America’s Pharmaceuticals Act passes on suspension calendar, but likely sets up fight with Senate in conference.